Feldman, F.; Koudoufio, M.; Sané, A.T.; Marcil, V.; Sauvé, M.F.; Butcher, J.; Patey, N.; Martel, C.; Spahis, S.; Duan, H.;
et al. Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action. Antioxidants 2025, 14, 268.
https://doi.org/10.3390/antiox14030268
AMA Style
Feldman F, Koudoufio M, Sané AT, Marcil V, Sauvé MF, Butcher J, Patey N, Martel C, Spahis S, Duan H,
et al. Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action. Antioxidants. 2025; 14(3):268.
https://doi.org/10.3390/antiox14030268
Chicago/Turabian Style
Feldman, Francis, Mireille Koudoufio, Alain Théophile Sané, Valérie Marcil, Mathilde Foisy Sauvé, James Butcher, Natalie Patey, Catherine Martel, Schohraya Spahis, Haonan Duan,
and et al. 2025. "Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action" Antioxidants 14, no. 3: 268.
https://doi.org/10.3390/antiox14030268
APA Style
Feldman, F., Koudoufio, M., Sané, A. T., Marcil, V., Sauvé, M. F., Butcher, J., Patey, N., Martel, C., Spahis, S., Duan, H., Figeys, D., Desjardins, Y., Stintzi, A., & Levy, E.
(2025). Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action. Antioxidants, 14(3), 268.
https://doi.org/10.3390/antiox14030268
